Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Larisa J. Geskin, Sara Viragova, Donna B. Stolz, et al.
Blood (2015) Vol. 125, Iss. 18, pp. 2798-2805
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors
Alyxzandria M. Gaydosik, Tracy Tabib, Larisa J. Geskin, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 14, pp. 4443-4454
Open Access | Times Cited: 116
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
Cancer Discovery (2016) Vol. 6, Iss. 9, pp. 986-1005
Open Access | Times Cited: 87
Targeting CD47 in Sézary syndrome with SIRPαFc
Lisa D. Johnson, Swati Banerjee, Oleg Kruglov, et al.
Blood Advances (2019) Vol. 3, Iss. 7, pp. 1145-1153
Open Access | Times Cited: 83
A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer
Pablo Vieyra-Garcia, Peter Wolf
Pharmacology & Therapeutics (2020) Vol. 222, pp. 107784-107784
Closed Access | Times Cited: 72
STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology
Georgia Karpathiou, Alexandra Papoudou‐Bai, Elise Ferrand, et al.
Pathology - Research and Practice (2021) Vol. 223, pp. 153477-153477
Open Access | Times Cited: 68
Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
Jingwei Shi, Xujun Song, Benno Traub, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2998-2998
Open Access | Times Cited: 57
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 11, pp. 1240-1240
Closed Access | Times Cited: 23
The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors
Renhao Li, Jingchu Hu, Rong Li, et al.
Cell Discovery (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Shanshan Wang, Ying Meng, Chengyi Li, et al.
Nanomaterials (2015) Vol. 6, Iss. 1, pp. 3-3
Open Access | Times Cited: 83
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
Nina A. Sibbesen, Katharina Kopp, Ivan V. Litvinov, et al.
Oncotarget (2015) Vol. 6, Iss. 24, pp. 20555-20569
Open Access | Times Cited: 82
IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells
Hui Cao, Jing Zhang, Hong Liu, et al.
Oncotarget (2016) Vol. 7, Iss. 38, pp. 61183-61198
Open Access | Times Cited: 81
A three‐signal model of T‐cell lymphoma pathogenesis
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 113-122
Open Access | Times Cited: 67
Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Leukemia (2019) Vol. 34, Iss. 3, pp. 845-856
Closed Access | Times Cited: 55
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 180-193
Open Access | Times Cited: 31
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7
Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma
Roberto Mazzetto, Paola Miceli, Jacopo Tartaglia, et al.
Life (2024) Vol. 14, Iss. 2, pp. 245-245
Open Access | Times Cited: 6
Tumor microenvironment in mycosis fungoides and Sézary syndrome
Belén Rubio González, Jasmine Zain, Steven T. Rosen, et al.
Current Opinion in Oncology (2015) Vol. 28, Iss. 1, pp. 88-96
Closed Access | Times Cited: 58
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis
Gang Li, Adriana T. Larregina, Robyn T. Domsic, et al.
Journal of Investigative Dermatology (2016) Vol. 137, Iss. 5, pp. 1042-1050
Open Access | Times Cited: 57
Novel insights into the pathogenesis of T-cell lymphomas
John S. Van Arnam, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson
Blood (2018) Vol. 131, Iss. 21, pp. 2320-2330
Open Access | Times Cited: 54
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
Veronica Stolearenco, Martin R. J. Namini, Siri S. Hasselager, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
Acceleration of cutaneous T-cell lymphoma following dupilumab administration
Kristen Russomanno, Cynthia Marie Carver DeKlotz
JAAD Case Reports (2020) Vol. 8, pp. 83-85
Open Access | Times Cited: 39
Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer
Marta Jaén, Ángela Martín‐Regalado, Rubén A. Bartolomé, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188802-188802
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top